You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 130 No. 8, August 1995 TABLE OF CONTENTS
  Archives
  •  Online Features
  Papers
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Total Vascular Exclusion for Major Hepatectomy in Patients With Abnormal Liver Parenchyma

Jean Emond, MD; Michael E. Wachs, MD; John F. Renz, MD, PhD; Scott Kelley, MD; Hobart Harris, MD; John P. Roberts, MD; Nancy L. Ascher, MD, PhD; Robert C. Lim, Jr, MD

Arch Surg. 1995;130(8):824-831.


Abstract

Background
Total vascular exclusion (TVE) of the liver has been used to increase the safety of hepatectomy and the feasibility of difficult resections. Until recently, however, concern about the detrimental effect of warm ischemia has limited the use of this technique to patients with normal liver parenchyma.

Objective
To compare surgical outcomes of 12 patients with abnormal livers (group 1) with outcomes of 48 patients with normal parenchyma (group 2), based on the hypothesis that uncontrolled bleeding may be more detrimental than planned hepatic ischemia.

Design and Setting
Retrospective analysis of 60 consecutive patients undergoing liver resection under TVE in a university medical center.

Patients
All 10 patients with cirrhosis had albumin levels of 30 g/L or higher and normal prothrombin times preoperatively; none had ascites. Two patients with cholestasis (one with cholangiocarcinoma and one with hepatocellular carcinoma) are included in group 1.

Intervention
All 12 group 1 patients and 44 of 48 group 2 patients underwent total or extended lobectomy, with TVE induced by clamping the hilum and the vena cava above and below the liver during parenchyma division.

Main Outcome Measures
Hospital survival and selected surgical and laboratory parameters.

Results
Operative times, ischemic times, and blood loss (1975±1601 vs 1255±1291 mL) (P=.10) were comparable in both groups. Sixty-day operative mortality was zero in both groups. There was an increased rate of complications in group 1 (44% vs 17% [P=.06]). Transient abnormal liver function was observed in both groups. However, significant delay in restoration of normal function was observed in group 1 with respect to bilirubin levels and prothrombin time.

Conclusions
Patients with cirrhosis can undergo successful resection using TVE. This conclusion must be limited to cirrhotic patients with good liver function. The trend toward increased blood loss may reflect greater difficulties in establishing hemostasis after reperfusion in group 1. While this group appears to have a higher risk for hepatic insufficiency, successful outcomes were achieved in all cases. Prospective study will be required to define the parameters for use of TVE in cirrhosis.

(Arch Surg. 1995;130:824-831)



Author Affiliations

From the Departments of Surgery (Drs Emond, Wachs, Renz, Roberts, Ascher, and Lim) and Anesthesia (Dr Kelley), University of California, San Francisco, and the Department of Surgery, San Francisco General Hospital (Dr Harris).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Total Vascular Exclusion of the Liver During Hepatic Surgery: Selective Use, Extensive Use, or Abuse?
Grazi et al.
Arch Surg 1997;132:1104-1109.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.